“…As of March 2009, more than 2,500 men have been treated with 125 I monotherapy. In previous reports, our group has provided detailed oncologic outcomes for a cohort consisting of the first of 1,006 consecutive brachytherapy patients (18,19). In those reports, 57 men were identified whose PSA profile triggered the nadir PSA + 2 ng/mL À1 definition.…”